Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Lung Cancer. According to GlobalData, Phase I drugs for Lung Cancer have a 78% phase transition success ...
Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Angiosarcoma. According to GlobalData, Phase I drugs for Angiosarcoma does not have sufficient ...
Aviator bet nacional Can drugs really make people rejuvenate? FDA releases latest results of Johnson & Johnson's single-dose COVID-19 vaccine showi ...
INR:6298. fifa world cup final 2023 The first traditional Chinese medicine for the prevention and treatment of COVID-19 has received clinical approval N ...
INR:4020. fctv live Molecular Completes $12.2 Million Series A Financing to Develop Enzymatic DNA Synthesis Technology Fosun Pharma's senior management changes! Vice Pr ...
INR:6891. horse race odds Huiyu Pharmaceutical's Paclitaxel Injection to be included in the priority review The root cause of autoimmune diseases is revealed: it ...
INR:7791. dragon tiger tips Fosun Pharma's recombinant anti-EGFR humanized monoclonal antibody injection showed good efficacy in Phase I clinical trial New drug ...
INR:7572. bet365 sportsbook nj Huiyu Pharmaceutical's Paclitaxel Injection to be included in the priority review The most eye-catching varieties in the secon ...